The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis
Authors:
Open Access
- 6 August 2024
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 157, 106978
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Utrecht
- ZonMw (10140021910002)
This publication has 51 references indexed in Scilit:
- The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography‐defined sarcopenia evaluation in patients with head and neck cancerHead & Neck, 2023
- The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapyCancer Medicine, 2022
- Image-based analysis of skeletal muscle mass predicts cisplatin dose-limiting toxicity in patients with locally advanced head and neck cancerEuropean Archives of Oto-Rhino-Laryngology, 2022
- Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle massHead & Neck, 2021
- Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2020
- Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancerClinical Nutrition, 2020
- Disease‐induced and treatment‐induced alterations in body composition in locally advanced head and neck squamous cell carcinomaJournal of Cachexia, Sarcopenia and Muscle, 2019
- Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancerHead & Neck, 2019
- Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebraEuropean Archives of Oto-Rhino-Laryngology, 2019
- The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology, 2017